GLOBAL MEDICAL REIT INC (GMRE) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:GMRE - US37954A3032 - REIT
33.03 USD
+0.21 (+0.64%)
We assign a fundamental rating of 3 out of 10 to GMRE. GMRE was compared to 128 industry peers in the Diversified REITs industry. GMRE has a bad profitability rating. Also its financial health evaluation is rather negative. GMRE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GMRE had positive earnings in the past year.
GMRE had a positive operating cash flow in the past year.
GMRE had positive earnings in 4 of the past 5 years.
GMRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GMRE has a Return On Assets of -0.26%. This is comparable to the rest of the industry: GMRE outperforms 40.63% of its industry peers.
GMRE has a Return On Equity (-0.69%) which is in line with its industry peers.
The Return On Invested Capital of GMRE (2.18%) is worse than 60.94% of its industry peers.
GMRE had an Average Return On Invested Capital over the past 3 years of 2.29%. This is in line with the industry average of 3.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.26% | ||
| ROE | -0.69% | ||
| ROIC | 2.18% |
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
1.3 Margins
GMRE's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 23.29%, GMRE is in line with its industry, outperforming 52.34% of the companies in the same industry.
GMRE's Operating Margin has declined in the last couple of years.
GMRE does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.29% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GMRE is destroying value.
The number of shares outstanding for GMRE has been increased compared to 1 year ago.
GMRE has more shares outstanding than it did 5 years ago.
GMRE has a worse debt/assets ratio than last year.
2.2 Solvency
GMRE has an Altman-Z score of 0.14. This is a bad value and indicates that GMRE is not financially healthy and even has some risk of bankruptcy.
GMRE's Altman-Z score of 0.14 is on the low side compared to the rest of the industry. GMRE is outperformed by 69.53% of its industry peers.
A Debt/Equity ratio of 1.46 is on the high side and indicates that GMRE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.46, GMRE perfoms like the industry average, outperforming 42.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.46 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.14 |
ROIC/WACC0.35
WACC6.18%
2.3 Liquidity
A Current Ratio of 0.33 indicates that GMRE may have some problems paying its short term obligations.
GMRE's Current ratio of 0.33 is on the low side compared to the rest of the industry. GMRE is outperformed by 84.38% of its industry peers.
A Quick Ratio of 0.33 indicates that GMRE may have some problems paying its short term obligations.
GMRE has a worse Quick ratio (0.33) than 83.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.33 | ||
| Quick Ratio | 0.33 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 950.00% over the past year.
Measured over the past years, GMRE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.74% on average per year.
Looking at the last year, GMRE shows a small growth in Revenue. The Revenue has grown by 6.14% in the last year.
GMRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.44% yearly.
EPS 1Y (TTM)950%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%8.65%
3.2 Future
The Earnings Per Share is expected to grow by 23.08% on average over the next years. This is a very strong growth
GMRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.43% yearly.
EPS Next Y480.13%
EPS Next 2Y123.94%
EPS Next 3Y98.13%
EPS Next 5Y23.08%
Revenue Next Year6.91%
Revenue Next 2Y6%
Revenue Next 3Y5.52%
Revenue Next 5Y3.43%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 194.29, which means the current valuation is very expensive for GMRE.
60.94% of the companies in the same industry are cheaper than GMRE, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.11. GMRE is valued rather expensively when compared to this.
GMRE is valuated quite expensively with a Price/Forward Earnings ratio of 164.65.
The rest of the industry has a similar Price/Forward Earnings ratio as GMRE.
GMRE is valuated expensively when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 194.29 | ||
| Fwd PE | 164.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GMRE is valued a bit cheaper than 70.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.63 |
4.3 Compensation for Growth
GMRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GMRE's earnings are expected to grow with 98.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y123.94%
EPS Next 3Y98.13%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.81%, GMRE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.34, GMRE pays a better dividend. On top of this GMRE pays more dividend than 94.53% of the companies listed in the same industry.
GMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.81% |
5.2 History
The dividend of GMRE is nicely growing with an annual growth rate of 37.64%!
GMRE has paid a dividend for at least 10 years, which is a reliable track record.
GMRE has decreased its dividend in the last 3 years.
Dividend Growth(5Y)37.64%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
The earnings of GMRE are negative and hence is the payout ratio. GMRE will probably not be able to sustain this dividend level.
GMRE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-1886.35%
EPS Next 2Y123.94%
EPS Next 3Y98.13%
NYSE:GMRE (12/2/2025, 11:09:00 AM)
33.03
+0.21 (+0.64%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners69.6%
Inst Owner Change-77.24%
Ins Owners0.35%
Ins Owner Change2.49%
Market Cap442.93M
Revenue(TTM)144.97M
Net Income(TTM)-3.33M
Analysts80
Price Target41.37 (25.25%)
Short Float %6.46%
Short Ratio3.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.81% |
Yearly Dividend4.96
Dividend Growth(5Y)37.64%
DP-1886.35%
Div Incr Years0
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-95.33%
Min EPS beat(2)-132.68%
Max EPS beat(2)-57.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-4.34%
Max Revenue beat(2)5.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-4.34%
Max Revenue beat(4)5.24%
Revenue beat(8)2
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-2.18%
Revenue beat(16)3
Avg Revenue beat(16)-1.81%
PT rev (1m)-9.55%
PT rev (3m)352.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)140%
EPS NY rev (1m)0%
EPS NY rev (3m)241.23%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 194.29 | ||
| Fwd PE | 164.65 | ||
| P/S | 3.06 | ||
| P/FCF | N/A | ||
| P/OCF | 6.15 | ||
| P/B | 0.91 | ||
| P/tB | 1.03 | ||
| EV/EBITDA | 12.63 |
EPS(TTM)0.17
EY0.51%
EPS(NY)0.2
Fwd EY0.61%
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)5.37
OCFY16.25%
SpS10.81
BVpS36.19
TBVpS31.98
PEG (NY)0.4
PEG (5Y)N/A
Graham Number11.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.26% | ||
| ROE | -0.69% | ||
| ROCE | 2.75% | ||
| ROIC | 2.18% | ||
| ROICexc | 2.19% | ||
| ROICexgc | 2.32% | ||
| OM | 23.29% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
ROICexc(3y)2.3%
ROICexc(5y)2.11%
ROICexgc(3y)2.52%
ROICexgc(5y)2.3%
ROCE(3y)2.9%
ROCE(5y)2.66%
ROICexgc growth 3Y-3.14%
ROICexgc growth 5Y-2.71%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y-2.82%
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.46 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.84 | ||
| Cap/Depr | 229.77% | ||
| Cap/Sales | 89.9% | ||
| Interest Coverage | 1.16 | ||
| Cash Conversion | 79.54% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.33 | ||
| Quick Ratio | 0.33 | ||
| Altman-Z | 0.14 |
F-Score3
WACC6.18%
ROIC/WACC0.35
Cap/Depr(3y)155.62%
Cap/Depr(5y)302.85%
Cap/Sales(3y)63.21%
Cap/Sales(5y)120.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)950%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%-33.33%
EPS Next Y480.13%
EPS Next 2Y123.94%
EPS Next 3Y98.13%
EPS Next 5Y23.08%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%8.65%
Revenue Next Year6.91%
Revenue Next 2Y6%
Revenue Next 3Y5.52%
Revenue Next 5Y3.43%
EBIT growth 1Y-3.06%
EBIT growth 3Y-3.87%
EBIT growth 5Y3.82%
EBIT Next Year181%
EBIT Next 3Y47.05%
EBIT Next 5Y31.78%
FCF growth 1Y-196.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.88%
OCF growth 3Y0.52%
OCF growth 5Y13.97%
GLOBAL MEDICAL REIT INC / GMRE FAQ
Can you provide the ChartMill fundamental rating for GLOBAL MEDICAL REIT INC?
ChartMill assigns a fundamental rating of 3 / 10 to GMRE.
What is the valuation status for GMRE stock?
ChartMill assigns a valuation rating of 3 / 10 to GLOBAL MEDICAL REIT INC (GMRE). This can be considered as Overvalued.
How profitable is GLOBAL MEDICAL REIT INC (GMRE) stock?
GLOBAL MEDICAL REIT INC (GMRE) has a profitability rating of 3 / 10.
What are the PE and PB ratios of GLOBAL MEDICAL REIT INC (GMRE) stock?
The Price/Earnings (PE) ratio for GLOBAL MEDICAL REIT INC (GMRE) is 194.29 and the Price/Book (PB) ratio is 0.91.
What is the expected EPS growth for GLOBAL MEDICAL REIT INC (GMRE) stock?
The Earnings per Share (EPS) of GLOBAL MEDICAL REIT INC (GMRE) is expected to grow by 480.13% in the next year.